New MD Anderson-Developed Breast Cancer Staging System Emphasizes Importance of Tumor Biology as Prognostic Indicator (The University of Texas MD Anderson Cancer Center)
A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer.
The University of Texas MD Anderson Cancer Center is one of the 26 NCCN Member Institutions.
...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Texas University | Women